Related Experiment Video
Updated: May 17, 2026
07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Progress in emerging therapies for advanced prostate cancer
1Service d'Oncologie Médicale, Hôpital Européen Georges Pompidou, Université Paris Descartes, Paris 5, Paris, France. stephane.oudard@egp.aphp.fr
Cancer Treatment Reviews
|October 31, 2012
Summary
New therapies are emerging for advanced prostate cancer, including hormone-sensitive and castration-resistant stages. Approved agents and those in phase III trials offer new treatment options for patients.
Area of Science:
- Oncology
- Urology
- Pharmacology
Background:
- Prostate cancer treatment is evolving with new therapeutic options.
- Extensive research is identifying novel agents for advanced disease stages.
Purpose of the Study:
- To review emerging therapies for advanced prostate cancer.
- Focus on agents approved in the USA and EU or in phase III trials.
Main Methods:
- Literature review of recent advancements in prostate cancer therapy.
- Emphasis on approved drugs and late-stage clinical studies.
Main Results:
- Degarelix approved for hormone-sensitive prostate cancer.
- Sipuleucel-T approved in the USA for pre-docetaxel treatment.
- Cabazitaxel, abiraterone acetate, and enzalutamide approved for castration-resistant prostate cancer.
- Denosumab approved for skeletal-related events in bone metastases.
- Radium-223 chloride shows promise in phase III trials.
Conclusions:
- Several new therapies have been approved for various stages of prostate cancer.
- These agents expand treatment options for advanced prostate cancer.
- Ongoing clinical studies suggest continued progress in prostate cancer management.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...